Novavax Inc (NAS:NVAX)
$ 7.87 -0.080 (-1.01%) Market Cap: 1.30 Bil Enterprise Value: 876.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Novavax Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 10:00 PM GMT
Release Date Price: $9.23 (-4.05%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NVAX.OQ - Novavax Inc
Novavax Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Session with Novavax. My name is Alex Stranahan. I cover Smith Biotech at Bank of America, and I'm the analyst covering Novavax. And it's my pleasure to introduce and be joined here by John Jacobs, President and CEO of Novavax, as well as Jim Kelly, Chief Financial Officer. Guys, thanks for being here again.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks for having us here. It's always a pleasure.

--------------------------------------------------------------------------------
Unidentified_1 [3]
----------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot